Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 14.28 is 72% above its 1-year average of 8.30, near the high end of its 1-year range (0.00–14.28).
As of the fiscal period ended Tuesday, June 30, 2026. 28.96% above its 12-month average of 11.07.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.28.
QUICK RATIO (ACID-TEST)
14.28
QUICK RATIO (ACID-TEST) AVG TTM
11.07
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.96%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+326.27%
vs the sector median at left
First Tracks Biotherapeutics Inc
Market Cap
$1.09B
Quick Ratio (Acid-Test)
14.28
TTM Avg
11.07
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.08B
Quick Ratio (Acid-Test)
8.13
TTM Avg
7.23
3Y Avg
6.69
5Y Avg
8.24
Market Cap
$1.08B
Quick Ratio (Acid-Test)
11.59
TTM Avg
21.25
3Y Avg
14.51
5Y Avg
14.51
Market Cap
$1.10B
Quick Ratio (Acid-Test)
4.03
TTM Avg
3.74
3Y Avg
4.48
5Y Avg
4.84
Market Cap
$1.10B
Quick Ratio (Acid-Test)
2.65
TTM Avg
2.17
3Y Avg
2.96
5Y Avg
3.83
Market Cap
$1.10B
Quick Ratio (Acid-Test)
5.23
TTM Avg
6.37
3Y Avg
10.25
5Y Avg
15.62
Market Cap
$1.10B
Quick Ratio (Acid-Test)
2.93
TTM Avg
3.33
3Y Avg
2.34
5Y Avg
2.11
Market Cap
$1.05B
Quick Ratio (Acid-Test)
0.81
TTM Avg
2.16
3Y Avg
2.71
5Y Avg
2.89
Market Cap
$1.12B
Quick Ratio (Acid-Test)
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| First Tracks Biotherapeutics Inc (TRAX) | $1.09B | 14.28 | 11.07 | N/A | N/A |
| IRadimed Corporation (IRMD)vs › | $1.08B | 8.13 | 7.23 | 6.69 | 8.24 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.08B | 11.59 | 21.25 | 14.51 | 14.51 |
| STAAR Surgical Company (STAA)vs › | $1.10B | 4.03 | 3.74 | 4.48 | 4.84 |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.10B | 2.65 | 2.17 | 2.96 | 3.83 |
| Replimune Group, Inc. (REPL)vs › | $1.10B | 5.23 | 6.37 | 10.25 | 15.62 |
| OPKO Health, Inc. (OPK)vs › | $1.10B | 2.93 | 3.33 | 2.34 | 2.11 |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 0.81 | 2.16 | 2.71 | 2.89 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.12B | 33.10 | 10.19 | 10.19 | 10.19 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 1.71 | 2.54 | 2.42 | 2.25 |
Quick Ratio
14.28
Excludes inventory
Current Ratio
14.28
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 14.28 |
| 2026-03-31 | 8.74 |
| 2025-12-31 | 10.20 |
| 2025-03-31 | 0.00 |
